Sabra Healthcare Net Worth
Sabra Healthcare Net Worth Breakdown | SBRA |
Sabra Healthcare Net Worth Analysis
Sabra Healthcare's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Sabra Healthcare's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Sabra Healthcare's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Sabra Healthcare's net worth analysis. One common approach is to calculate Sabra Healthcare's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Sabra Healthcare's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Sabra Healthcare's net worth. This approach calculates the present value of Sabra Healthcare's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Sabra Healthcare's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Sabra Healthcare's net worth. This involves comparing Sabra Healthcare's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Sabra Healthcare's net worth relative to its peers.
Enterprise Value |
|
To determine if Sabra Healthcare is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Sabra Healthcare's net worth research are outlined below:
| Sabra Healthcare REIT currently holds 2.45 B in liabilities with Debt to Equity (D/E) ratio of 0.76, which is about average as compared to similar companies. Sabra Healthcare REIT has a current ratio of 0.76, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Sabra Healthcare's use of debt, we should always consider it together with its cash and equity. | |
| Sabra Healthcare has a poor financial position based on the latest SEC disclosures | |
| Over 99.0% of Sabra Healthcare shares are owned by institutional investors | |
| Latest headline from news.google.com: Sabra Health Care REIT, Inc. Stock Position Raised by Thrivent Financial for Lutherans - MarketBeat |
Sabra Healthcare uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Sabra Healthcare REIT. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Sabra Healthcare's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 20th of February 2024 Upcoming Quarterly Report | View | |
| 1st of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 20th of February 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Know Sabra Healthcare's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Sabra Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sabra Healthcare REIT backward and forwards among themselves. Sabra Healthcare's institutional investor refers to the entity that pools money to purchase Sabra Healthcare's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Dimensional Fund Advisors, Inc. | 2024-09-30 | 3.4 M | Deutsche Bank Ag | 2024-06-30 | 3.3 M | Northern Trust Corp | 2024-09-30 | 3.3 M | Jpmorgan Chase & Co | 2024-06-30 | 3.1 M | Norges Bank | 2024-06-30 | 2.8 M | Apg Investments Us Inc | 2024-06-30 | 2.6 M | Systematic Financial Management Lp | 2024-09-30 | 2.3 M | Duff & Phelps Inv Mgmt Co (il) | 2024-06-30 | 2 M | Advisors Capital Management, Llc | 2024-09-30 | 1.9 M | Vanguard Group Inc | 2024-09-30 | 34.9 M | Blackrock Inc | 2024-06-30 | 34.4 M |
Follow Sabra Healthcare's market capitalization trends
The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.36 B.Market Cap |
|
Project Sabra Healthcare's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Capital Employed | 0.06 | 0.05 |
When accessing Sabra Healthcare's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Sabra Healthcare's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Sabra Healthcare's profitability and make more informed investment decisions.
Please note, the presentation of Sabra Healthcare's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Sabra Healthcare's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of Sabra Healthcare's management manipulating its earnings.
Evaluate Sabra Healthcare's management efficiency
Sabra Healthcare REIT has return on total asset (ROA) of 0.0283 % which means that it generated a profit of $0.0283 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.0346 %, meaning that it created $0.0346 on every $100 dollars invested by stockholders. Sabra Healthcare's management efficiency ratios could be used to measure how well Sabra Healthcare manages its routine affairs as well as how well it operates its assets and liabilities. As of November 25, 2024, Return On Tangible Assets is expected to decline to 0. In addition to that, Return On Capital Employed is expected to decline to 0.05. At present, Sabra Healthcare's Other Assets are projected to increase significantly based on the last few years of reporting. The current year's Total Current Assets is expected to grow to about 387.9 M, whereas Total Assets are forecasted to decline to about 4.2 B.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 12.12 | 12.46 | |
| Tangible Book Value Per Share | 11.99 | 12.22 | |
| Enterprise Value Over EBITDA | 13.64 | 12.96 | |
| Price Book Value Ratio | 1.18 | 1.53 | |
| Enterprise Value Multiple | 13.64 | 12.96 | |
| Price Fair Value | 1.18 | 1.53 | |
| Enterprise Value | 5.7 B | 3.2 B |
The strategic initiatives led by Sabra Healthcare's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Enterprise Value Revenue 9.9243 | Revenue 683.2 M | Quarterly Revenue Growth 0.107 | Revenue Per Share 2.943 | Return On Equity 0.0346 |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Sabra Healthcare insiders, such as employees or executives, is commonly permitted as long as it does not rely on Sabra Healthcare's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Sabra Healthcare insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Sabra Healthcare Corporate Filings
8K | 12th of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
13A | 18th of October 2024 An amended filing to the original Schedule 13G | ViewVerify |
F4 | 19th of September 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
| 26th of April 2024 Other Reports | ViewVerify |
Sabra Healthcare Earnings per Share Projection vs Actual
Sabra Healthcare Corporate Management
| Jessica Flores | Chief VP | Profile | |
| Peter Nyland | Executive Management | Profile | |
| Michael Costa | CFO VP | Profile | |
| Eliza Gozar | Senior Investments | Profile | |
| Darrin Smith | Executive Investments | Profile |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Sabra Healthcare REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Sabra Healthcare. If investors know Sabra will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Sabra Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.111 | Dividend Share 1.2 | Earnings Share 0.41 | Revenue Per Share 2.943 | Quarterly Revenue Growth 0.107 |
The market value of Sabra Healthcare REIT is measured differently than its book value, which is the value of Sabra that is recorded on the company's balance sheet. Investors also form their own opinion of Sabra Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Sabra Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Sabra Healthcare's market value can be influenced by many factors that don't directly affect Sabra Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Sabra Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Sabra Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Sabra Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.